• News
  • Finance

Biogen Idec rises on Citi analyst upgrade

Shares of Biogen Idec Inc. rose Friday after a Citi Investment Research analyst upgraded the stock, saying he expects Biogen to take a commanding share of the market for multiple sclerosis drugs.

To continue reading, subscribe now
log in to your account
User Response
0 UserComments
Subscribe Today!